Giant cell arteritis (GCA) is the most common form of medium- and large-vessel vasculitis. Despite new treatment options for patients with GCA, delays in diagnosis and treatment lead to poor outcomes, such as the increased risk for visual impairments and incidence of heart attacks, transient ischemic attacks, and/or mortality. Diagnosis of GCA remains difficult due to the nonspecific nature of many early symptoms. Until recently, therapeutic options were limited to prolonged, high-dose glucocorticoid therapy, which has the potential for many undesirable side effects. In this Curbside Consults series, expert faculty will discuss clinical cases that emphasize appropriate medical work-up for timely identification of GCA and early intervention strategies, as well as provide guidance for implementing evidence-based glucocorticoid-sparing therapy. Experts will also discuss the importance of a multidisciplinary approach to optimize the work-up and care of patients with GCA.
In this podcast, clinical experts discuss key findings presented during the past year on current and emerging therapies for managing uncontrolled gout.
In this podcast, clinical experts discuss key findings presented during the past year on evidence-based tools for detection and assessment of uncontrolled gout.
In this podcast, clinical experts discuss key findings presented during the past year on disease burden and comorbidities associated with uncontrolled gout.
In this podcast, expert clinicians will discuss the current tools available for outpatient management of COVID-19 and provide updates on emerging options for preexposure prophylaxis.
In this podcast, expert clinicians will discuss current unmet needs regarding patient education and review strategic messaging to enhance the preparedness of immunocompromised patients at risk for COVID-19.
In this podcast, expert clinicians will discuss outpatient management of COVID-19 and strategies to educate practitioners on best practices for those caring for immunocompromised patients.
In this podcast, expert clinicians will discuss how immune compromising conditions and iatrogenic causes of immune suppression affect risk for infection and severe outcomes with COVID-19.
In this podcast, expert clinicians will review clinical cases of varying severity to highlight evidence-based approaches for management of EGPA.
In this podcast, expert clinicians will examine diagnostic approaches that can be used to distinguish EGPA from other vasculitides and hypereosinophilic conditions.
In this podcast, expert clinicians will discuss evidence-based practices on the appropriate use of glucocorticoids, immunosuppressants, and targeted therapy for induction and maintenance of remission in severe and non-severe forms of EGPA.
Stay up to date
For any inquiries, please email us at hello@podcastworld.io